BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 2470129)

  • 1. Structure and function of prostatic- and seminal vesicle-secreted proteins involved in the gelation and liquefaction of human semen.
    Lilja H
    Scand J Clin Lab Invest Suppl; 1988; 191():13-20. PubMed ID: 2470129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seminal vesicle-secreted proteins and their reactions during gelation and liquefaction of human semen.
    Lilja H; Oldbring J; Rannevik G; Laurell CB
    J Clin Invest; 1987 Aug; 80(2):281-5. PubMed ID: 3611349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of prostate-specific antigen proteolytic activity on its major physiological substrate, the sperm motility inhibitor precursor/semenogelin I.
    Robert M; Gibbs BF; Jacobson E; Gagnon C
    Biochemistry; 1997 Apr; 36(13):3811-9. PubMed ID: 9092810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution and tissue expression of semenogelin I and II in man as demonstrated by in situ hybridization and immunocytochemistry.
    Bjartell A; Malm J; Moller C; Gunnarsson M; Lundwall A; H Lilja
    J Androl; 1996; 17(1):17-26. PubMed ID: 8833737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The GPI-anchored CD52 antigen of the sperm surface interacts with semenogelin and participates in clot formation and liquefaction of human semen.
    Flori F; Ermini L; La Sala GB; Nicoli A; Capone A; Focarelli R; Rosati F; Giovampaola CD
    Mol Reprod Dev; 2008 Feb; 75(2):326-35. PubMed ID: 17624925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of a human seminal vesicle specific protein.
    Flickinger CJ; Herr JC; McGee RS; Sigman M; Evans RJ; Sutherland WM; Summers TA; Spell DR; Conklin DJ
    Andrologia; 1990; 22 Suppl 1():142-54. PubMed ID: 1720288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Semenogelin I: a coagulum forming, multifunctional seminal vesicle protein.
    Robert M; Gagnon C
    Cell Mol Life Sci; 1999 Jun; 55(6-7):944-60. PubMed ID: 10412373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell biology of semenogelin.
    Lilja H
    Andrologia; 1990; 22 Suppl 1():132-41. PubMed ID: 2132066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Advances in the study of Semenogelin I from human seminal vesicles].
    Su SF; Wang ZJ
    Zhonghua Nan Ke Xue; 2009 Apr; 15(4):364-6. PubMed ID: 19472915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and characterization of the active precursor of a human sperm motility inhibitor secreted by the seminal vesicles: identity with semenogelin.
    Robert M; Gagnon C
    Biol Reprod; 1996 Oct; 55(4):813-21. PubMed ID: 8879494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cloning of epididymal and seminal vesicular transcripts encoding a semenogelin-related protein.
    Lilja H; Lundwall A
    Proc Natl Acad Sci U S A; 1992 May; 89(10):4559-63. PubMed ID: 1584792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A major secretory protein from rat seminal vesicle binds ejaculated spermatozoa.
    Manco G; Abrescia P
    Gamete Res; 1988 Sep; 21(1):71-84. PubMed ID: 2906623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of the role of prostate-specific antigen in semen liquefaction by two-dimensional electrophoresis.
    Lee C; Keefer M; Zhao ZW; Kroes R; Berg L; Liu XX; Sensibar J
    J Androl; 1989; 10(6):432-8. PubMed ID: 2482840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-liquefaction of semen: a physiological therapeutic approach?
    Colpi GM; Balerna M; Campana A; Andò S
    Acta Eur Fertil; 1983; 14(4):261-4. PubMed ID: 6673444
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of seminal plasma on motion characteristics of epididymal and ejaculated stallion spermatozoa during storage at 5 degrees C.
    Braun J; Torres-Boggino F; Hochi S; Oguri N
    Dtsch Tierarztl Wochenschr; 1994 Aug; 101(8):319-22. PubMed ID: 7924976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional implications of membrane modification with semenogelins for inhibition of sperm motility in humans.
    Yoshida K; Krasznai ZT; Krasznai Z; Yoshiike M; Kawano N; Yoshida M; Morisawa M; Tóth Z; Bazsáné ZK; Márián T; Iwamoto T
    Cell Motil Cytoskeleton; 2009 Feb; 66(2):99-108. PubMed ID: 19089943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Origin of a sperm motility inhibitor from boar seminal plasma.
    Iwamoto T; Tanaka H; Osada T; Shinagawa T; Osamura Y; Gagnon C
    Mol Reprod Dev; 1993 Dec; 36(4):475-81. PubMed ID: 8305210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired secretory function of the prostate in men with oligo-asthenozoospermia.
    Ahlgren G; Rannevik G; Lilja H
    J Androl; 1995; 16(6):491-8. PubMed ID: 8867597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sperm motility inhibitor from human seminal plasma: presence of a precursor molecule in seminal vesicle fluid and its molecular processing after ejaculation.
    Robert M; Gagnon C
    Int J Androl; 1994 Oct; 17(5):232-40. PubMed ID: 7698848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neurophysiological effects of seminal vesicles].
    Wang DC; Wang JQ
    Zhonghua Nan Ke Xue; 2018 Apr; 24(4):360-363. PubMed ID: 30168959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.